APO RESEARCH · REPORT
Nerve Stimulator
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Product & engineering
Understand the product.
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Selected research
Industry Research
Nerve Stimulator Industry Research Report 2026
Market perspective
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Global Nerve Stimulator key players include Medtronic, Abbott, Boston Scientific, etc. Global top three manufacturers hold a share over 70%.
North America is the largest market, with a share about 80%, followed by China, and Europe, both have a share about 15 percent.
Read the full market overview
In terms of product, Spinal Cord Stimulator is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain Management, followed by Parkinson's Disease, Epilepsy, Incontinence, etc.
Report Scope
This report quantifies the global Nerve Stimulator market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nerve Stimulator Market by Company
Medtronic
Abbott
Boston Scientific
LivaNova
Nevro
Pins Medical
NeuroPace
Synapse Biomedical
Nerve Stimulator Segment by Type
Deep Brain Stimulator
Spinal Cord Stimulator
Vagus Nerve Stimulator
Nerve Stimulator Segment by Application
Pain Management
Parkinson's Disease
Incontinence
Epilepsy
Nerve Stimulator Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nerve Stimulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nerve Stimulator and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nerve Stimulator.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nerve Stimulator manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nerve Stimulator by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nerve Stimulator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Deep Brain Stimulator
- Spinal Cord Stimulator
- Vagus Nerve Stimulator
Applications
- Pain Management
- Parkinson's Disease
- Incontinence
- Epilepsy
Companies covered
- Medtronic
- Abbott
- Boston Scientific
- LivaNova
- Nevro
- Pins Medical
- NeuroPace
- Synapse Biomedical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nerve Stimulator Market Size (2021-2032)
- 2.2.2 Global Nerve Stimulator Sales (2021-2032)
- 2.2.3 Global Nerve Stimulator Market Average Price (2021-2032)
- 2.3 Nerve Stimulator by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Deep Brain Stimulator
- 2.3.3 Spinal Cord Stimulator
- 2.3.4 Vagus Nerve Stimulator
- 2.4 Nerve Stimulator by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pain Management
- 2.4.3 Parkinson's Disease
- 2.4.4 Incontinence
- 2.4.5 Epilepsy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nerve Stimulator Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nerve Stimulator Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Nerve Stimulator Revenue of Manufacturers (2021-2026)
- 3.4 Global Nerve Stimulator Average Price by Manufacturers (2021-2026)
- 3.5 Global Nerve Stimulator Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nerve Stimulator, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nerve Stimulator, Product Type & Application
- 3.8 Global Manufacturers of Nerve Stimulator, Established Date
- 3.9 Global Nerve Stimulator Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Nerve Stimulator Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Abbott
- 4.2.1 Abbott Company Information
- 4.2.2 Abbott Business Overview
- 4.2.3 Abbott Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Abbott Nerve Stimulator Product Portfolio
- 4.2.5 Abbott Recent Developments
- 4.3 Boston Scientific
- 4.3.1 Boston Scientific Company Information
- 4.3.2 Boston Scientific Business Overview
- 4.3.3 Boston Scientific Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boston Scientific Nerve Stimulator Product Portfolio
- 4.3.5 Boston Scientific Recent Developments
- 4.4 LivaNova
- 4.4.1 LivaNova Company Information
- 4.4.2 LivaNova Business Overview
- 4.4.3 LivaNova Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 LivaNova Nerve Stimulator Product Portfolio
- 4.4.5 LivaNova Recent Developments
- 4.5 Nevro
- 4.5.1 Nevro Company Information
- 4.5.2 Nevro Business Overview
- 4.5.3 Nevro Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nevro Nerve Stimulator Product Portfolio
- 4.5.5 Nevro Recent Developments
- 4.6 Pins Medical
- 4.6.1 Pins Medical Company Information
- 4.6.2 Pins Medical Business Overview
- 4.6.3 Pins Medical Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pins Medical Nerve Stimulator Product Portfolio
- 4.6.5 Pins Medical Recent Developments
- 4.7 NeuroPace
- 4.7.1 NeuroPace Company Information
- 4.7.2 NeuroPace Business Overview
- 4.7.3 NeuroPace Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 NeuroPace Nerve Stimulator Product Portfolio
- 4.7.5 NeuroPace Recent Developments
- 4.8 Synapse Biomedical
- 4.8.1 Synapse Biomedical Company Information
- 4.8.2 Synapse Biomedical Business Overview
- 4.8.3 Synapse Biomedical Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Synapse Biomedical Nerve Stimulator Product Portfolio
- 4.8.5 Synapse Biomedical Recent Developments
5 Global Nerve Stimulator Market Scenario by Region
- 5.1 Global Nerve Stimulator Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nerve Stimulator Sales by Region: 2021-2032
- 5.2.1 Global Nerve Stimulator Sales by Region: 2021-2026
- 5.2.2 Global Nerve Stimulator Sales by Region: 2027-2032
- 5.3 Global Nerve Stimulator Revenue by Region: 2021-2032
- 5.3.1 Global Nerve Stimulator Revenue by Region: 2021-2026
- 5.3.2 Global Nerve Stimulator Revenue by Region: 2027-2032
- 5.4 North America Nerve Stimulator Market Facts & Figures by Country
- 5.4.1 North America Nerve Stimulator Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nerve Stimulator Sales by Country (2021-2032)
- 5.4.3 North America Nerve Stimulator Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Nerve Stimulator Market Facts & Figures by Country
- 5.5.1 Europe Nerve Stimulator Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nerve Stimulator Sales by Country (2021-2032)
- 5.5.3 Europe Nerve Stimulator Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Nerve Stimulator Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nerve Stimulator Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nerve Stimulator Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nerve Stimulator Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nerve Stimulator Market Facts & Figures by Country
- 5.7.1 South America Nerve Stimulator Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nerve Stimulator Sales by Country (2021-2032)
- 5.7.3 South America Nerve Stimulator Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Nerve Stimulator Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nerve Stimulator Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nerve Stimulator Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nerve Stimulator Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Nerve Stimulator Sales by Type (2021-2032)
- 6.1.1 Global Nerve Stimulator Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Nerve Stimulator Sales Market Share by Type (2021-2032)
- 6.2 Global Nerve Stimulator Revenue by Type (2021-2032)
- 6.2.1 Global Nerve Stimulator Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nerve Stimulator Revenue Market Share by Type (2021-2032)
- 6.3 Global Nerve Stimulator Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nerve Stimulator Sales by Application (2021-2032)
- 7.1.1 Global Nerve Stimulator Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Nerve Stimulator Sales Market Share by Application (2021-2032)
- 7.2 Global Nerve Stimulator Revenue by Application (2021-2032)
- 7.2.1 Global Nerve Stimulator Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nerve Stimulator Revenue Market Share by Application (2021-2032)
- 7.3 Global Nerve Stimulator Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nerve Stimulator Value Chain Analysis
- 8.1.1 Nerve Stimulator Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nerve Stimulator Production Mode & Process
- 8.2 Nerve Stimulator Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nerve Stimulator Distributors
- 8.2.3 Nerve Stimulator Customers
9 Global Nerve Stimulator Analyzing Market Dynamics
- 9.1 Nerve Stimulator Industry Trends
- 9.2 Nerve Stimulator Industry Drivers
- 9.3 Nerve Stimulator Industry Opportunities and Challenges
- 9.4 Nerve Stimulator Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst